334 related articles for article (PubMed ID: 37268427)
21. Comparison of [
Jiang D; Chen X; You Z; Wang H; Zhang X; Li X; Ren S; Huang Q; Hua F; Guan Y; Zhao J; Xie F
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):732-742. PubMed ID: 34297193
[TBL] [Abstract][Full Text] [Related]
22. Comparison of 18 F-FDG PET/CT and 68 Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
Can C; Kepenek F; Kömek H; Gündoğan C; Kaplan İ; Taşdemir B; Güzel Y; Agüloğlu N; Karaoğlan H
Nucl Med Commun; 2022 Oct; 43(10):1084-1091. PubMed ID: 35972340
[TBL] [Abstract][Full Text] [Related]
23.
Fu H; Wu J; Huang J; Sun L; Wu H; Guo W; Qiu S; Chen H
Radiology; 2022 Aug; 304(2):397-405. PubMed ID: 35536131
[TBL] [Abstract][Full Text] [Related]
24. Comparison of [
Chen H; Pang Y; Wu J; Zhao L; Hao B; Wu J; Wei J; Wu S; Zhao L; Luo Z; Lin X; Xie C; Sun L; Lin Q; Wu H
Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1820-1832. PubMed ID: 32222810
[TBL] [Abstract][Full Text] [Related]
25. Comparisons of Quantitative Parameters of Ga-68-Labelled Fibroblast Activating Protein Inhibitor (FAPI) PET/CT and [
Siripongsatian D; Promteangtrong C; Kunawudhi A; Kiatkittikul P; Boonkawin N; Chinnanthachai C; Jantarato A; Chotipanich C
Mol Imaging Biol; 2022 Oct; 24(5):818-829. PubMed ID: 35486293
[TBL] [Abstract][Full Text] [Related]
26. The Added Value of
Gu B; Xu X; Zhang J; Ou X; Xia Z; Guan Q; Hu S; Yang Z; Song S
J Nucl Med; 2022 Jun; 63(6):875-881. PubMed ID: 34593594
[No Abstract] [Full Text] [Related]
27. Imaging fibroblast activation protein in liver cancer: a single-center post hoc retrospective analysis to compare [
Guo W; Pang Y; Yao L; Zhao L; Fan C; Ke J; Guo P; Hao B; Fu H; Xie C; Lin Q; Wu H; Sun L; Chen H
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1604-1617. PubMed ID: 33179149
[TBL] [Abstract][Full Text] [Related]
28. [
Wei Y; Cheng K; Fu Z; Zheng J; Mu Z; Zhao C; Liu X; Wang S; Yu J; Yuan S
Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1671-1681. PubMed ID: 34870727
[TBL] [Abstract][Full Text] [Related]
29. Accurate preoperative staging with [
Chen S; Chen Z; Zou G; Zheng S; Zheng K; Zhang J; Huang C; Yao S; Miao W
Eur Radiol; 2022 Sep; 32(9):6070-6079. PubMed ID: 35352157
[TBL] [Abstract][Full Text] [Related]
30. Head-to-head Intra-individual Comparison of [
Novruzov E; Dendl K; Ndlovu H; Choyke PL; Dabir M; Beu M; Novruzov F; Mehdi E; Guliyev F; Koerber SA; Lawal I; Niegisch G; Debus J; Haberkorn U; Sathekge M; Giesel FL
Mol Imaging Biol; 2022 Aug; 24(4):651-658. PubMed ID: 35349039
[TBL] [Abstract][Full Text] [Related]
31. Clinical utility of [
Zhao L; Pang Y; Zheng H; Han C; Gu J; Sun L; Wu H; Wu S; Lin Q; Chen H
Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3606-3617. PubMed ID: 33792760
[TBL] [Abstract][Full Text] [Related]
32. PET/CT imaging fibroblast activation protein in initial colorectal cancer: compared to 18 F-FDG PET/CT.
Dong Y; Sun P; Wu H; Zhong J; Cao M; Tang G; Zhou W
Nucl Med Commun; 2023 Nov; 44(11):1011-1019. PubMed ID: 37661771
[TBL] [Abstract][Full Text] [Related]
33. Comparison of [
Kömek H; Can C; Kaplan İ; Gündoğan C; Kepenek F; Karaoglan H; Demirkıran A; Ebinç S; Güzel Y; Gündeş E
Eur J Nucl Med Mol Imaging; 2022 Sep; 49(11):3898-3909. PubMed ID: 35578038
[TBL] [Abstract][Full Text] [Related]
34. Prospective Comparison of
Lan L; Zhang S; Xu T; Liu H; Wang W; Feng Y; Wang L; Chen Y; Qiu L
Radiology; 2022 Sep; 304(3):648-657. PubMed ID: 35579524
[TBL] [Abstract][Full Text] [Related]
35. Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study.
Li Y; Lin X; Li Y; Lv J; Hou P; Liu S; Chen P; Wang M; Zhou C; Wang X
Mol Imaging Biol; 2022 Apr; 24(2):309-320. PubMed ID: 34816283
[TBL] [Abstract][Full Text] [Related]
36. The role of [
Civan C; Kuyumcu S; Has Simsek D; Sanli O; Isik EG; Ozkan ZG; Hurdogan O; Sanli Y
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):852-861. PubMed ID: 37803246
[TBL] [Abstract][Full Text] [Related]
37. Head-to-head comparison of
Zhang J; Jiang S; Li M; Xue H; Zhong X; Li S; Peng H; Liang J; Liu Z; Rao S; Chen H; Cao Z; Gong Y; Chen G; Zhang R; Zhang L
Cancer Imaging; 2023 Oct; 23(1):106. PubMed ID: 37899452
[TBL] [Abstract][Full Text] [Related]
38.
Dendl K; Koerber SA; Finck R; Mokoala KMG; Staudinger F; Schillings L; Heger U; Röhrich M; Kratochwil C; Sathekge M; Jäger D; Debus J; Haberkorn U; Giesel FL
Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):4089-4100. PubMed ID: 34050777
[TBL] [Abstract][Full Text] [Related]
39. Biodistribution, pharmacokinetics, dosimetry of [
Ballal S; Yadav MP; Moon ES; Kramer VS; Roesch F; Kumari S; Tripathi M; ArunRaj ST; Sarswat S; Bal C
Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1915-1931. PubMed ID: 33244617
[TBL] [Abstract][Full Text] [Related]
40.
Kessler L; Hirmas N; Pabst KM; Hamacher R; Ferdinandus J; Schaarschmidt BM; Milosevic A; Nader M; Umutlu L; Uhl W; Reinacher-Schick A; Lugnier C; Witte D; Niedergethmann M; Herrmann K; Fendler WP; Siveke JT
J Nucl Med; 2023 Dec; 64(12):1910-1917. PubMed ID: 37973185
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]